-The Indian Express Delhi lost the window of opportunity to avoid an outbreak because of a governance deficit; first because the state was in election mode and then because of the AAP’s internal squabbles. The past few weeks have witnessed substantial media coverage on the dengue outbreak in Delhi. Heartrending stories of clearly avoidable deaths gave the crisis a human face. Focusing on Delhi, most sought to expose the lack of...

-The Hindu The idea of attacking poverty by increasing mobile connectivity in a country that ranks 55 in the Global Hunger Index is just fantasy Interviewer: What would you regard as the most outstanding and significant event of the last decade? Siddhartha: The… war in Vietnam, sir. Interviewer: More significant than landing on the moon? Siddhartha: I think so, sir. — “Pratidwandi” (The Adversary), 1970 The most fundamental debate for our youth is the choice between Android,...

-Down to Earth India’s Public Spending on Health is among the lowest in South East Asia and BRIC countries The burden of aspirations and expectations seems to be taking a toll on young India, especially males who succumb to suicidal deaths more than their female counterparts, according to the data published by the Central Bureau of Health Intelligence (CBHI). The data showed that over 67 per cent cases of suicidal deaths in...

-The Times of India NEW DELHI: Despite liberalization of the insurance sector, only around 21.6 crore people - less than one-fifth of India's population - are covered under health insurance. Even among those who have some form of coverage, 67% are covered by public insurance companies, according to National Health Profile 2015, compiled by the Central Bureau of Health Intelligence. The report, which has a separate chapter on health financing, shows despite...

-The Times of India WASHINGTON: India has agreed to supply to the United States generic cancer drugs at a time there is outrage in America about the predatory practices by the US pharma industry, one of whose leaders is getting hammered for increasing the price of life-saving drugs by as much as 5000 per cent overnight. Martin Shkreli, CEO of Turing Pharmaceuticals, is being dubbed the ''poster child for price gouging in...